✦ LIBER ✦

244 Tamoxifen as a potential inhibitor of the chemotherapy resistance in non-small cell lung cancer

✍ Scribed by T.A. Bogush; E.A. Dudko; E.A. Bogush; M.V. Tikchomirov; R.J. Ramanayskaite; K.K. Laktionov; B.E. Polotsky; M.I. Davydov

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy resistance and oncogene exp

✍ Thomas A. d‘Amato; Rodney J. Landreneau; William Ricketts; Weidong Huang; Ricard 📂 Article 📅 2007 🏛 CTSNet 🌐 English ⚖ 323 KB

Chemotherapy of non-small cell lung canc

✍ Gridelli, Cesare 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 90 KB

The role of chemotherapy in non-small ce

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 60 KB

IFOSFAMIDE AS SINGLE-AGENT CHEMOTHERAPY

✍ Peake, M.D.; Parker, D. 📂 Article 📅 1985 🏛 The Lancet 🌐 English ⚖ 320 KB

Subsequent Chemotherapy Improves Surviva

✍ Chih-Hsi Kuo; Shu-Min Lin; Kang-Yun Lee; Fu-Tsai Chung; Meng-Heng Hsieh; Yueh-Fu 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 338 KB

Transglutaminase 2 as a cisplatin resist

✍ Kang-Seo Park; Hyun-Kyoung Kim; Jung-Hwa Lee; Yong-Bock Choi; Seong-Yeol Park; S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 583 KB